A carregar...
CDK4/6 inhibition in luminal breast cancer
Endocrine therapy represents the basis for the treatment of estrogen receptor-positive breast cancer, but several tumors harbor intrinsic resistance and acquired resistance to endocrine therapy is inevitable in metastatic disease. Combination strategies of endocrine therapy with targeted agents are...
Na minha lista:
| Publicado no: | Memo |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Vienna
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4923084/ https://ncbi.nlm.nih.gov/pubmed/27429659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-016-0268-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|